Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic cord blood (3 trials)
cord blood hematopoietic stem cell (1 trial)
lithium (lithonate) (2 trials)
umbilical cord mesenchymal stem cells (2 trials)
Brain Ischemia (Phase 1)
Cerebral Infarction (Phase 1)
Ischemia (Phase 1)
Spinal Cord Injuries (Phase 2)
Stroke (Phase 1)
Wounds and Injuries (Phase 2)
Trials (6 total)
Trial APIs (4 total)